Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    Study C38072/3084
Show Display Options
Rank Status Study
1 Completed
Has Results
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Condition: Eosinophilic Asthma
Interventions: Drug: Reslizumab;   Drug: Placebo

Study has passed its completion date and status has not been verified in more than two years.